CD24 - Wikipedia
CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils [6] and neutrophil precursors from the …
Nature：癌症免疫疗法新靶点——CD24 - 雪球
Aug 5, 2019 · CD24，全称为cluster of differentiation 24，又称热稳定抗原，是一种高度糖基化的糖基磷脂酰肌醇锚定表面蛋白，已知与先天免疫细胞上的 Siglec-10 （sialic-acid-binding Ig …
CD24：后起之秀，没有血液毒性的天然免疫检查点 - 知乎
1978年，科学家首次发现CD24，即分化簇24（Cluster of differentiation 24），也称为热稳定抗原（heat-stable antigen，HSA)，一种高度糖基化的糖基磷脂酰肌醇 (GPI)锚定的膜蛋白。 CD24 …
Targeting CD24 as a novel immunotherapy for solid cancers
Nov 2, 2023 · Cluster of differentiation 24 (CD24), a mucin-like highly glycosylated molecule has been extensively studied as a cancer stem cell marker in a variety of solid cancers. The …
CD24 Gene - GeneCards | CD24 Protein | CD24 Antibody
Dec 24, 2024 · CD24 (CD24 Molecule) is a Protein Coding gene. Diseases associated with CD24 include Erythroleukemia and Multiple Sclerosis. Among its related pathways are Nervous …
CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy
CD24, is a mucin-like GPI-anchored molecules. By immunohistochemistry, it is widely detected in many solid tumors, such as breast cancers, genital system cancers, digestive system cancers, …
CD24: from A to Z | Cellular & Molecular Immunology - Nature
Feb 15, 2010 · In the adaptive immune response, CD24 is a redundant costimulatory molecule in costimulation-rich lymphoid organs but is essential in selected target organs tested, such as...
CD24 signalling through macrophage Siglec-10 is a target for …
Genetic ablation and therapeutic blockade of CD24 resulted in a macrophage-dependent reduction of tumour growth in vivo and an increase in survival time. These data reveal CD24 …
CD24 signalling through macrophage Siglec-10 is a target for ... - Nature
Jul 31, 2019 · We demonstrate a role for tumour-expressed CD24 in promoting immune evasion through its interaction with the inhibitory receptor sialic-acid-binding Ig-like lectin 10 (Siglec …
金斯瑞解读｜肿瘤免疫治疗领域的新秀-CD24 - 百家号
Jan 13, 2021 · CD24-Fc是由OncoImmune公司的华人科学家刘阳教授多年的研究成果，于2020年11月23日被默沙东以4.25亿美元预付款进行收购，这一合作金额也打破了License-out的纪录 …